Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Outpatient Gabapentin Rarely Used for Approved Indications
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Psychedelic Drug Shows Promise in Treatment-Resistant Depression
Dyanavel XR Oral Tablets Approved for ADHD
Cariprazine Promising as Adjunctive Treatment for Major Depressive Disorder
Lybalvi Now Available for Schizophrenia, Bipolar I Disorder
Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Psychological Treatment Provides Pain Relief for Chronic Back Pain
Relapse Risk Up With Antidepressant Therapy Discontinuation
Insulin Resistance Linked to Risk for Major Depressive Disorder
Isotretinoin Does Not Up Suicide Risk in Acne Patients
Drug Therapy for Borderline Personality Disorder Evaluated
Viloxazine Under Review for ADHD Treatment in Adults
Invega Hafyera Approved for Twice-Yearly Treatment of Schizophrenia
Application for Long-Acting Schizophrenia Treatment Accepted for Review
Opioid Tapering Tied to Higher Risk for Overdose, Mental Health Crisis
Transcranial Magnetic Stimulation Device Cleared for Anxious Depression
Lyme Disease Tied to Higher Risk for Psychiatric Conditions, Suicide